Addition of Hydroxyurea to Fludarabine, Cytarabine, Idarubicin and Venetoclax Salvage Therapy for Adults With Relapsed or Refractory Acute Myeloid Leukemia

26 participants · First posted Aug 17, 2026

Study of the Beach Regimen on Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

32 participants · First posted Jun 16, 2026

Lopinavir/r or Fosamprenavir/r Switch to Atazanavir/r or Darunavir/r

49 participants · First posted Sep 22, 2008

(R,R')-penehyclidine fumarate

(R,R)-2,3-Butanediol

C₄H₁₀O₂

R&R, Inc.

United States

Anabio R&D

Vietnam

R-Biopharm AG

Germany

SynOx Therapeutics Reports Positive Phase 3 Results for Emactuzumab in Tenosynovial Giant Cell Tumor

P-BCMA-ALLO1 Demonstrates Promising Efficacy and Safety in Relapsed/Refractory Multiple Myeloma

Navtemadlin Shows Promise in JAK Inhibitor-Refractory Myelofibrosis